The root causes of most forms of Alzheimer's disease largely remain a mystery. Now, researchers have revealed a new piece of the puzzle.

Using a new technology and computational method, researchers from Fred Hutch Cancer Center and The University of Texas MD ...

The general mood among these heavyweight investors is divided, with 37% leaning bullish and 37% bearish. Among these notable options, 4 are puts, totaling $366,099, and 4 are calls, amounting to ...

The genomics industry is set for growth due to advancements in personalized medicine, diagnostics, and biotech innovations.

An MTF2-containing subcomplex of Polycomb Repressive Complex 2 promotes cell cycle progression through repression of D-type cyclin expression in certain cellular contexts.

Analysis By Technology, By Workflow, By Application, By End User, By Region Size and Trends - Forecast up to 2029" report has been added to ResearchAndMarkets.com's offering. The global oncology NGS ...

Angle announces new results for dual analysis of CTC-DNA and ctDNA using Illumina assay and sequencing platform: London Saturday, February 1, 2025, 15:00 Hrs [IST] Angle plc, a wo ...

Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, State Key Laboratory for Digestive Health, National Clinical Research Center for Digestive Disease, Beijing ...

You may have heard of the big names in the business, like Illumina, Oxford Nanopore Technologies ... sample pinpoints tumor-related alterations at the DNA level, RNA sequencing confirms mutations in ...

enabling analysis of large gene panels and cancer specific mutations. Illumina is the world's largest provider of NGS systems and assays and has built an installed base of more than 23,000 sequencing ...